STAFF BOARD
Article
CHAIRMAN
Manuela Velázquez Prieto
EDITOR IN CHIEF
Jaime E. Poquet Jornet
MARKETING MANAGER
EDITORIAL BOARD
Tomás Casasín Edo
Virginia Hernández Corredoira
Ramón Jódar Masanés
Juan Carlos Juárez Giménez
Volume 20 - Issue 6, November-December 2018
ORIGINAL
DETECTING PHARMACOVIGILANCE SIGNALS: DATA MINING OF BENZODIAZEPINES ADVERSE REACTIONS NOTIFIED TO FDA REPORTING SYSTEM
PROY VEGA BEATRIZ, MARTÍNEZ BLÁZQUEZ ANSELMO, SOLÍS-GARCÍA DEL POZO JULIÁN, JORDÁN JOAQUÍN


Since patients have easier access to information, thanks to the growing development of technology, their concern about everything related to drugs, especially adverse drug reactions, has increased. Resulting of this, authorities and health agencies are increasingly interested in drug safety and early detection of signals. Quantitative signals detection methods are useful for detecting pharmacovigilance signals, which can be analyzed to establish causality between an adverse event and a drug. Goal of this study was to deepen in signal detection of adverse drug reactions potentially associated to benzodiazepines, through the analysis of spontaneous notifiations reported to the United States pharmacovigilance database (FAERS);after a previous work of signals detection of only cutaneous adverse reactions associated to this family of drugs, by applying data mining technique and different algorithms. All this, initially motivated by the market withdrawal of medicines
containing tetrazepam in 2013, due to serious adverse skin reactions after the analysis of the suspected adverse reactions reported to the French pharmacovigilance database. The most frequently reported adverse reaction to FAERS associated to benzodiazepines marketed in the United States were analyzed. Our statistical analysis
revealed the following signals generated by different algorithmic methods of disproportionality analysis: when Proportional Reporting Ratio applied, only a single signal for estazolam and «Cardiac disorders» was detected. Reporting Odd Ratio algorithm detected 31, the largest number of signals. With Information Component, 24 signals were detected. Finally, using Empirical Bayesian Geometric Mean algorithm, two signals were detected: one for clobazam and «Nervous system disorders», and another for quazepam and «Lesions, intoxications and
procedural complications». All these adverse events are described in the Summary of Product Characteristic of these drugs, in different frequencies. A signal is a suggestion that there is a statistical association between a medication and an event. Calculating signals does not provide an estimation of the incidence of adverse reaction or information about whether a statistical association between a drug and an adverse reaction is causal, but highlights potential drug problems that draw the attention of the pharmacovigilance community for investigating in more detail to maximize safety of the drug.

ADVERSE DRUG REACTION – BENZODIAZEPINES – PHARMACOVIGILANCE – SIGNAL – SPONTANEOUS REPORTING



Fill out the form below to buy this article

Name and surname:

DNI/NIF ID/VAT IDENTIFICATION No.:

Contact Email:

Phone:

Address:

Zip code:

City:

Province:

Country:

*I have read and accept the privacy policy
Price : 30,25